跳至主要内容
临床试验/JPRN-UMIN000024643
JPRN-UMIN000024643已完成2 期

A phase II study of S-1 plus cisplatin with concurrent radiation for locally advanced thymic carcinoma (LOGIK1605/JART-1501) - A phase II study of S-1 plus cisplatin with concurrent radiation for locally advanced thymic carcinoma (LOGIK1605/JART-1501)

Clinical Research Support Center Kyushu0 个研究点目标入组 30 人开始时间: 2016年10月31日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who requires urgent radiation therapy with a symptom of superior vena cava syndrome. 2. Patients with serious complications : such as uncontrollable angina pectoris, myocardial infarction within 3 months and heart failure, uncontrollable diabetes mellitus,hypertension and serious infection. 3. Patients with interstitial pneumonia confirmed by chest X-ray. 4. Patients having complications judged to affect the enforcement of treatment. 5. Patients with anamnesis of severe hypersensitivity. 6. Patients with pregnant or possibly pregnant.Patients with nursing. 7. Patients who are different for the participation in the study by complication of mental disease or psychiatric symptom. 8. Any other patients who are regarded as unsuitable for this study by the investigators.

研究者

发起方
Clinical Research Support Center Kyushu

相似试验